NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis $0.46 -0.02 (-4.17%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$0.46▼$0.5150-Day Range$0.46▼$0.6352-Week Range$0.40▼$2.94Volume316,979 shsAverage Volume368,858 shsMarket Capitalization$145.41 millionP/E RatioN/ADividend YieldN/APrice Target$4.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get P3 Health Partners alerts: Email Address P3 Health Partners MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside878.3% Upside$4.50 Price TargetShort InterestHealthy1.41% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.15Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($0.23) to ($0.25) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.34 out of 5 starsMedical Sector606th out of 910 stocksHealth Services Industry5th out of 11 stocks 3.3 Analyst's Opinion Consensus RatingP3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageP3 Health Partners has received no research coverage in the past 90 days.Read more about P3 Health Partners' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.41% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 5.34%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PIII. Previous Next 1.7 News and Social Media Coverage News SentimentP3 Health Partners has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for P3 Health Partners this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for PIII on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders17.86% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.75% of the stock of P3 Health Partners is held by institutions.Read more about P3 Health Partners' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for P3 Health Partners are expected to decrease in the coming year, from ($0.23) to ($0.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -0.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -0.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about P3 Health Partners' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Golden CrestBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide << About P3 Health Partners Stock (NASDAQ:PIII)P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.Read More PIII Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PIII Stock News HeadlinesSeptember 7 at 3:43 AM | americanbankingnews.comP3 Health Partners (NASDAQ:PIII) Stock Price Down 3.4%September 5 at 10:27 AM | markets.businessinsider.comP3 Health Partners (PIII) Gets a Buy from Lake StreetSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 30, 2024 | finance.yahoo.comP3 Health Partners Names Leif Pedersen New Chief Financial OfficerAugust 26, 2024 | finance.yahoo.comP3 Health Partners Inc.'s (NASDAQ:PIII) market cap dropped US$9.5m last week; Private equity firms bore the bruntJuly 24, 2024 | finance.yahoo.comP3 Health Partners Schedules Second Quarter 2024 Earnings Release and Conference CallMay 28, 2024 | businesswire.comP3 Health Partners to Present at Upcoming Investor ConferencesMay 28, 2024 | investorplace.comWhy Is P3 Health Partners (PIII) Stock Down 4% Today?September 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. May 23, 2024 | businesswire.comP3 Health Partners Inc. Announces Approximately $42.2 Million Private PlacementMay 12, 2024 | finance.yahoo.comP3 Health Partners Inc. (NASDAQ:PIII) Q1 2024 Earnings Call TranscriptMay 9, 2024 | businesswire.comP3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 8, 2024 | finance.yahoo.comP3 Health Partners Announces First Quarter 2024 ResultsMay 8, 2024 | finance.yahoo.comP3 Health Partners Names Dr. Aric Coffman as CEOMay 2, 2024 | businesswire.comP3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference CallApril 3, 2024 | businesswire.comP3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 28, 2024 | benzinga.comP3 Health Partners: Q4 Earnings InsightsMarch 28, 2024 | finance.yahoo.comP3 Health Partners Inc. Reports Revenue Growth and Affirms 2024 Guidance, Despite Net LossSee More Headlines Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2024Today9/07/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:PIII CUSIPN/A CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees500Year FoundedN/APrice Target and Rating Average Stock Price Target$4.50 High Stock Price Target$4.50 Low Stock Price Target$4.50 Potential Upside/Downside+878.3%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-57,770,000.00 Net Margins-4.95% Pretax Margin-12.80% Return on Equity-43.19% Return on Assets-7.93% Debt Debt-to-Equity Ratio0.80 Current Ratio0.69 Quick Ratio0.69 Sales & Book Value Annual Sales$1.40 billion Price / Sales0.10 Cash Flow$0.09 per share Price / Cash Flow5.36 Book Value$0.47 per share Price / Book0.98Miscellaneous Outstanding Shares316,115,000Free Float259,657,000Market Cap$145.41 million OptionableNot Optionable Beta1.17 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Sherif Abdou F.A.C.E.P. (Age 63)FACP, M.D., Co-Founder, Director & Strategic Advisor Comp: $1.04MDr. Amir Bacchus M.B.A. (Age 59)M.D., Co-Founder, Chief Medical Officer & Director Comp: $780kMr. Atul KavthekarCFO & Chief Accounting OfficerMr. William BettermannExecutive VP & COOMr. Devery GoodeySenior Vice President of TechnologyRoy YoungbloodDirector of ComplianceLeslie P. FisherSenior VP of Legal Affairs, General Counsel & Corporate SecretaryMs. Kassi Belz APRExecutive Vice President of Communications, Culture & EngagementMr. Todd Lefkowitz MHAChief Managed Care OfficerMs. Sarah Bussmann B.S.N.CRNI, M.H.A., R.N., Chief of StaffMore ExecutivesKey CompetitorsFrontier InvestmentNASDAQ:FICVGlobal Consumer AcquisitionNASDAQ:GACQOrion Biotech OpportunitiesNASDAQ:ORIAGoGreen InvestmentsNYSE:GOGNCelcuityNASDAQ:CELCView All CompetitorsInsiders & InstitutionsArmistice Capital LLCBought 7,900,000 shares on 8/15/2024Ownership: 2.499%Renaissance Technologies LLCBought 73,000 shares on 8/9/2024Ownership: 0.035%Emfo LLCBought 406,418 shares on 7/27/2024Ownership: 0.452%Sanders Morris Harris LLCBought 20,000 shares on 7/12/2024Ownership: 0.045%Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/13/2023Total: $238,500.00 ($2.65/share)View All Insider TransactionsView All Institutional Transactions PIII Stock Analysis - Frequently Asked Questions How have PIII shares performed this year? P3 Health Partners' stock was trading at $1.41 at the start of the year. Since then, PIII stock has decreased by 67.4% and is now trading at $0.46. View the best growth stocks for 2024 here. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) announced its earnings results on Wednesday, August, 7th. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.07. The firm earned $379.16 million during the quarter, compared to the consensus estimate of $364.50 million. P3 Health Partners had a negative trailing twelve-month return on equity of 43.19% and a negative net margin of 4.95%. Who are P3 Health Partners' major shareholders? P3 Health Partners' top institutional investors include Armistice Capital LLC (2.50%), Emfo LLC (0.45%), Sanders Morris Harris LLC (0.05%) and Renaissance Technologies LLC (0.04%). Insiders that own company stock include Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago, Sherif Abdou, Atul Kavthekar and Michael Balkin. View institutional ownership trends. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PIII) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PIII Stock Alerts